About Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2000. It develops and manufactures Active Pharmaceutical Ingredients and drug intermediates for domestic and international markets. It operates on a B2B model. The company has 67 employees. Its website vaasavaa.com draws about 681 thousand monthly visits. Its Indian entity Vaasavaa Pharmaceuticals Private Limited reported revenue of ₹59.28 Cr. Vaasavaa Pharmaceuticals offers products and services including Active Pharmaceutical Ingredients and Drug Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing and Drug Intermediates. Its competitors include Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Vaasavaa Pharmaceuticals Private Limited specializes in developing and producing Active Pharmaceutical Ingredients (APIs) and their intermediates. The company operates a manufacturing facility in Solapur, Maharashtra, India, and a corporate office in Hyderabad, Telangana, India. It serves both domestic and international markets, adhering to WHO GMP and DCA GMP standards. Quality assurance activities include analysis of raw materials and products, while maintaining departments for production, warehouse, and maintenance to ensure compliance and efficiency.
- Headquarters Hyderabad, India
- Employees 67
- SectorsHealthcare
- Email••••••••
- Website vaasavaa.com
- Legal Name Vaasavaa Pharmaceuticals Private Limited
- Date of Incorporation 17 Jul, 2000
- Jurisdiction Solapur, Maharashtra, India
- Annual Revenue₹59.28 Cr
FY 2025 · +16% YoY
- Net Profit₹1.79 Cr
FY 2025 · 3% margin
- EBITDA₹4.85 Cr
FY 2025 · 8% margin
- Employee Count67
Associated legal entities of Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals operates through Vaasavaa Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vaasavaa Pharmaceuticals Private Limited CIN U24232PN2000PTC015122 | Active | 17 Jul 2000 | Solapur, Maharashtra | ₹59.3 Cr | 67 | 4 | View details |
Products & Services of Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Drug Intermediates.
Produces APIs for use in drug formulations
Manufactures intermediates for API production
Board of directors of Vaasavaa Pharmaceuticals Private Limited (Vaasavaa Pharmaceuticals)
Vaasavaa Pharmaceuticals Private Limited is the primary company behind Vaasavaa Pharmaceuticals. The board of Vaasavaa Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Murali Krishna Prasad Koneru, appointed in 2000. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Murali Krishna Prasad Koneru DIN 02042080 | Director | 17 Jul 2000 | 26 yrs 3 mo | Vaasavaa Pharmaceuticals Private Limited |
| Subbarao Chandraskhar Rao Movva DIN 01913323 | Director | 17 Jul 2000 | 26 yrs 3 mo | Vaasavaa Pharmaceuticals Private Limited |
| Narasimha Rao Polavarapu DIN 02042073 | Director | 23 Jun 2003 | 23 yrs 3 mo | Vaasavaa Pharmaceuticals Private Limited |
| Sri Ram Dhanekula DIN 06599445 | Director | 04 Jul 2013 | 13 yrs 3 mo | Vaasavaa Pharmaceuticals Private Limited |
Financials of Vaasavaa Pharmaceuticals
Figures of Vaasavaa Pharmaceuticals Private Limited, the primary company behind Vaasavaa Pharmaceuticals, for FY 2025. Revenue was ₹59.28 Cr (+16% year on year). Net profit was ₹1.79 Cr (3% margin). EBITDA was ₹4.85 Cr (8% margin). Revenue has grown at a compounded annual rate of -8% over three years and +10% over five years.
- ₹59.28 CrRevenue · FY 2025 · +16% YoY
- ₹1.79 CrNet profit · 3% margin
- ₹4.85 CrEBITDA · 8% margin
- ₹1.42 CrPaid-up capital
- 67Employees (provident fund records)
- -8%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vaasavaa Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Vaasavaa Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals has 9 listed competitors in our database, 4 of them funded. They include Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | – | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs | |
| amiorganics.com | 2007 | Surat, India | – | 4 | Advanced API intermediates are manufactured for pharmaceutical use. | |
| aparnapharma.com | 2008 | Hyderabad, India | $674,328 | 328 | API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | |
| dudechem.com | 2019 | Berlin, Germany | $6.98M | – | CDMO focused on manufacturing of APIs and intermediates | |
| hindyslab.com | 2007 | Hyderabad, India | – | 285 | Manufactures and exports pharmaceutical intermediates for global markets. | |
| hsbiopharm.com | 2004 | Hangzhou, China | – | – | APIs, intermediates, and finished dosage forms are manufactured. | |
| enantilabs.com | 2007 | Hyderabad, India | – | 178 | Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. |
Detailed competitors of Vaasavaa Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vaasavaa Pharmaceuticals
The website of Vaasavaa Pharmaceuticals (vaasavaa.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Vaasavaa Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Vaasavaa Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Vaasavaa Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vaasavaa Pharmaceuticals
Vaasavaa Pharmaceuticals was founded in 2000.
Vaasavaa Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Vaasavaa Pharmaceuticals has 67 employees.
The primary company behind Vaasavaa Pharmaceuticals, Vaasavaa Pharmaceuticals Private Limited, reported revenue of ₹59.28 Cr for FY 2025, up 16% year on year.
Vaasavaa Pharmaceuticals Private Limited specializes in developing and producing Active Pharmaceutical Ingredients (APIs) and their intermediates. The company operates a manufacturing facility in Solapur, Maharashtra, India, and a corporate office in Hyderabad, Telangana, India. It serves both domestic and international markets, adhering to WHO GMP and DCA GMP standards. Quality assurance activities include analysis of raw materials and products, while maintaining departments for production, warehouse, and maintenance to ensure compliance and efficiency.
Vaasavaa Pharmaceuticals's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Vaasavaa Pharmaceuticals offers Active Pharmaceutical Ingredients and Drug Intermediates.
Vaasavaa Pharmaceuticals operates through Vaasavaa Pharmaceuticals Private Limited.
The legal entities of Vaasavaa Pharmaceuticals currently have 4 directors, including Narasimha Rao Polavarapu, Murali Krishna Prasad Koneru, Sri Ram Dhanekula and others.
The website of Vaasavaa Pharmaceuticals receives about 681 thousand visits a month.